Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ENHANCE: Prolonged-Release Fampridine in MS
NCT02219932Phase 3Completed
- Sponsor
- Biogen
- Start
- Sep 2014
- Primary completion
- Feb 2016
- Modality
- Small Molecules
- Countries
- 11
01
Overview
A Phase 3 trial of fampridine in multiple sclerosis (MS), sponsored by Biogen. Started Sep 2014; status: completed.
02
Drugs
fampridine
03
Conditions
multiple sclerosis (MS)
Beyond the preview
Go deeper on NCT02219932.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02219932.